HUMULIN N OTC

Select the drug indication to add to your list

HUMULIN N

Diabetes
Only 4 drugs may be compared at once

Generic Name and Formulations:

Insulin isophane suspension (NPH) (human, rDNA origin) 100 Units/mL; inj.

Select therapeutic use:

Indications for HUMULIN N:

Diabetes.

Adults and Children:

SC injection only. Onset approx 1–2hrs, peak 6–12hrs, duration 18–24hrs.

Warnings/Precautions:

Instruct patients on diet, exercise, blood or urine testing, proper administration of insulin, change in species of origin, type or purity of insulin, and management of hypoglycemia. Do not reuse or share pens, needles, or syringes between patients. Dosage increase may be required during infection, illness, stress, trauma, and pregnancy. Dosage decrease may be needed with renal or hepatic dysfunction.

Interactions:

Concomitant thiazolidinediones (TZDs) may cause fluid retention and heart failure; consider dose reduction or discontinue TZDs. Potentiated by oral antidiabetic agents, pramlintide, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, propoxyphene, salicylates, somatostatin analog, sulfonamide antibiotics. Antagonized by corticosteroids, isoniazid, niacin, danazol, diuretics, thiazides, phenothiazines, sympathomimetics, somatropin, thyroid hormones, estrogens, progestogens, atypical antipsychotics. Variable effects with β-blockers, clonidine, lithium salts, alcohol, pentamidine. Onset may be delayed if regular insulin is mixed with zinc insulin. Regular and NPH insulins may be mixed and used immediately or stored for future use.

See Also:

HUMULIN 70/30

HUMULIN R U-100

HUMULIN R U-500

Adverse Reactions:

Hypoglycemia, hypokalemia, local or systemic allergy, lipodystrophy, edema.

How Supplied:

Vials 70/30, N, R (U-100)—10mL; R (U-500)—20mL; KwikPen (70/30, N)—5x3mL; R (U-500)—2x3mL, 5x3mL

HUMULIN N five 3ml kwikpens of 100 units/ml cartons (Qty:1)

appx. price $447.00